30
Participants
Start Date
December 18, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
June 30, 2027
Tucatinib Oral Tablet
300 mg, twice daily
Capecitabine tablets
1000 mg/m², twice daily on days 1-14 of each 21-day cycle
Trastuzumab Injection
Intrathecal by lumbar puncture or Ommaya Reservoir, 150 mg weekly
RECRUITING
Centre Henri Becquerel, Rouen
RECRUITING
Centre François Baclesse, Caen
RECRUITING
Centre Georges-François Leclerc, Dijon
NOT_YET_RECRUITING
Institut Bergonié, Bordeaux
RECRUITING
Institut régional du Cancer de Montpellier, Montpellier
RECRUITING
Institut Jean Godinot, Reims
RECRUITING
Centre Jean Perrin, Clermont-Ferrand
RECRUITING
Institut de cancérologie Strasbourg Europe - ICANS, Strasbourg
RECRUITING
Centre Léon Bérard, Lyon
RECRUITING
Gustave Roussy, Villejuif
RECRUITING
Centre Antoine Lacassagne, Nice
Seagen Inc.
INDUSTRY
UNICANCER
OTHER